Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.
Vahidy FS, Haque ME, Rahbar MH, Zhu H, Rowan P, Aisiku IP, Lee DA, Juneja HS, Alderman S, Barreto AD, Suarez JI, Bambhroliya A, Hasan KM, Kassam MR, Aronowski J, Gee A, Cox CS Jr, Grotta JC, Savitz SI.
Vahidy FS, et al. Among authors: zhu h.
Stem Cells. 2019 Nov;37(11):1481-1491. doi: 10.1002/stem.3080. Epub 2019 Sep 17.
Stem Cells. 2019.
PMID: 31529663
Clinical Trial.